1. Home
  2. VRAX vs HAO Comparison

VRAX vs HAO Comparison

Compare VRAX & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • HAO
  • Stock Information
  • Founded
  • VRAX 2013
  • HAO 2018
  • Country
  • VRAX United Kingdom
  • HAO China
  • Employees
  • VRAX N/A
  • HAO 30
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HAO
  • Sector
  • VRAX Health Care
  • HAO
  • Exchange
  • VRAX Nasdaq
  • HAO NYSE
  • Market Cap
  • VRAX 7.3M
  • HAO 6.6M
  • IPO Year
  • VRAX 2022
  • HAO 2024
  • Fundamental
  • Price
  • VRAX $1.87
  • HAO $1.85
  • Analyst Decision
  • VRAX
  • HAO
  • Analyst Count
  • VRAX 0
  • HAO 0
  • Target Price
  • VRAX N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • VRAX 304.3K
  • HAO 7.0M
  • Earning Date
  • VRAX 02-05-2025
  • HAO 10-29-2024
  • Dividend Yield
  • VRAX N/A
  • HAO N/A
  • EPS Growth
  • VRAX N/A
  • HAO 20.20
  • EPS
  • VRAX N/A
  • HAO 0.04
  • Revenue
  • VRAX $84,872.00
  • HAO $48,519,836.00
  • Revenue This Year
  • VRAX $5,169.18
  • HAO N/A
  • Revenue Next Year
  • VRAX $66.97
  • HAO N/A
  • P/E Ratio
  • VRAX N/A
  • HAO $2.47
  • Revenue Growth
  • VRAX 7.03
  • HAO 71.88
  • 52 Week Low
  • VRAX $0.60
  • HAO $0.09
  • 52 Week High
  • VRAX $9.00
  • HAO $10.60
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 48.66
  • HAO 57.14
  • Support Level
  • VRAX $1.65
  • HAO $1.71
  • Resistance Level
  • VRAX $2.10
  • HAO $2.11
  • Average True Range (ATR)
  • VRAX 0.22
  • HAO 0.20
  • MACD
  • VRAX 0.01
  • HAO -0.09
  • Stochastic Oscillator
  • VRAX 42.47
  • HAO 21.21

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: